Ventus Medical's Provent Sleep Apnea Therapy granted CE Mark

Mar 3 2011

Ventus Medical, Inc. a privately-held medical device company dedicated to providing novel products to treat sleep-disordered breathing, today announced that it has received CE Mark for its Provent® Sleep Apnea Therapy.

"We are pleased to accomplish this important regulatory milestone. Receiving CE Mark for Provent Therapy will facilitate our international commercialization strategy and allow us to launch this product in selected countries over the next several months," said Peter Wyles, president and chief executive officer of Ventus Medical. "We intend to introduce Provent Therapy internationally in a systematic way through established distributors, focusing on countries with a high prevalence of obstructive sleep apnea. There is a clear need for therapeutic options other than CPAP and Provent Therapy represents an attractive new alternative."